Arrowstreet Capital’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$28.2M Buy
129,030
+87,679
+212% +$19.2M 0.02% 579
2025
Q1
$9.26M Buy
+41,351
New +$9.26M 0.01% 828
2023
Q2
Sell
-4,508
Closed -$1.56M 1503
2023
Q1
$1.56M Buy
4,508
+3,298
+273% +$1.14M ﹤0.01% 967
2022
Q4
$285K Buy
+1,210
New +$285K ﹤0.01% 1215
2022
Q3
Sell
-77,108
Closed -$23.3M 1480
2022
Q2
$23.3M Sell
77,108
-179,585
-70% -$54.3M 0.03% 349
2022
Q1
$105M Sell
256,693
-250,181
-49% -$103M 0.13% 168
2021
Q4
$238M Sell
506,874
-8,274
-2% -$3.88M 0.29% 82
2021
Q3
$219M Buy
515,148
+153,180
+42% +$65M 0.27% 83
2021
Q2
$130M Sell
361,968
-16,395
-4% -$5.89M 0.16% 138
2021
Q1
$107M Buy
378,363
+129,527
+52% +$36.5M 0.14% 144
2020
Q4
$70.5M Buy
248,836
+62,320
+33% +$17.7M 0.1% 186
2020
Q3
$51.3M Buy
186,516
+162,003
+661% +$44.5M 0.08% 234
2020
Q2
$5.57M Sell
24,513
-76,210
-76% -$17.3M 0.01% 1020
2020
Q1
$15.3M Buy
100,723
+65,588
+187% +$9.99M 0.04% 363
2019
Q4
$5.28M Sell
35,135
-103,467
-75% -$15.6M 0.01% 840
2019
Q3
$19.7M Buy
138,602
+26,429
+24% +$3.75M 0.05% 348
2019
Q2
$14M Buy
112,173
+33,562
+43% +$4.2M 0.03% 406
2019
Q1
$8.66M Buy
+78,611
New +$8.66M 0.02% 601
2018
Q3
Sell
-11,700
Closed -$1.16M 1281
2018
Q2
$1.16M Buy
+11,700
New +$1.16M ﹤0.01% 774
2017
Q4
Sell
-3,800
Closed -$366K 1416
2017
Q3
$366K Sell
3,800
-137,113
-97% -$13.2M ﹤0.01% 980
2017
Q2
$13.3M Buy
140,913
+84,100
+148% +$7.95M 0.04% 315
2017
Q1
$4.64M Buy
+56,813
New +$4.64M 0.02% 587
2016
Q3
Sell
-5,000
Closed -$379K 1655
2016
Q2
$379K Buy
+5,000
New +$379K ﹤0.01% 1191
2014
Q3
Sell
-28,455
Closed -$1.2M 1138
2014
Q2
$1.2M Sell
28,455
-107,764
-79% -$4.54M 0.01% 682
2014
Q1
$6M Buy
+136,219
New +$6M 0.04% 404